134 related articles for article (PubMed ID: 32156139)
1. Adjuvant chemotherapy improves the prognosis of early stage resectable pulmonary large cell carcinoma: analysis of SEER data.
Hu X; Tai Q; Su B; Zhang L
Ann Palliat Med; 2020 Mar; 9(2):199-206. PubMed ID: 32156139
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
Ann Thorac Surg; 2011 Oct; 92(4):1180-6; discussion 1186-7. PubMed ID: 21867986
[TBL] [Abstract][Full Text] [Related]
4. The Clinical Characteristics and Treatments for Large Cell Carcinoma Patients Older than 65 Years Old: A Population-Based Study.
Yao A; Liang L; Rao H; Shen Y; Wang C; Xie S
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358648
[TBL] [Abstract][Full Text] [Related]
5. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
6. Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.
Zheng X; Mu S; Wang L; Tao H; Huang D; Huang Z; Li X; Cui P; Li T; Liu Q; Hu Y
BMC Pulm Med; 2023 Jan; 23(1):12. PubMed ID: 36635639
[TBL] [Abstract][Full Text] [Related]
7. Effect of Chemotherapy in Stage II-IV Large-Cell Lung Carcinoma and Construction of Its Predictive Nomograms: A SEER Analysis.
Hu G; Liu Y; Li X; Jin M; Liu X; Yu Q
Med Princ Pract; 2023; 32(1):49-60. PubMed ID: 36652925
[TBL] [Abstract][Full Text] [Related]
8. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
9. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases.
Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; Calabrò F; Casali C; Marulli G; Spaggiari L
Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis.
Malhotra J; Mhango G; Gomez JE; Smith C; Galsky MD; Strauss GM; Wisnivesky JP
Ann Oncol; 2015 Apr; 26(4):768-773. PubMed ID: 25600562
[TBL] [Abstract][Full Text] [Related]
11. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
12. Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer.
Xu Y; Wan B; Zhu S; Zhang T; Xie J; Liu H; Zhan P; Lv T; Song Y
Front Oncol; 2021; 11():784289. PubMed ID: 35155190
[TBL] [Abstract][Full Text] [Related]
13. The role of postoperative radiotherapy (PORT) in pulmonary large cell neuroendocrine carcinoma (PLCNEC).
Gang Jin ; Lili Xue ; Xiang Song
Cancer Radiother; 2020 Jun; 24(3):215-221. PubMed ID: 32156456
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma.
Meng FJ; Sun ZN; Wang ZN; Ma HM; Zhang WC; Gao ZY; Ji LL; Feng FK; Yang B; Wang CY; Chen ZY; Zhang N; Wang GS
Thorac Cancer; 2021 Sep; 12(18):2439-2448. PubMed ID: 34337871
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor standardized uptake value (SUVmax) measured on
Hui Z; Wei F; Ren H; Xu W; Ren X
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
[TBL] [Abstract][Full Text] [Related]
17. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Pisters KM; Vallières E; Crowley JJ; Franklin WA; Bunn PA; Ginsberg RJ; Putnam JB; Chansky K; Gandara D
J Clin Oncol; 2010 Apr; 28(11):1843-9. PubMed ID: 20231678
[TBL] [Abstract][Full Text] [Related]
18. Lung Large Cell Neuroendocrine Carcinoma: An Analysis of Patients from the Surveillance, Epidemiology, and End-Results (SEER) Database.
Deng C; Wu SG; Tian Y
Med Sci Monit; 2019 May; 25():3636-3646. PubMed ID: 31095532
[TBL] [Abstract][Full Text] [Related]
19. A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients.
Sun F; Ma K; Yang X; Li M; Shi Y; Zhan C; Jiang W; Wang Q
Int J Surg; 2017 Jun; 42():11-16. PubMed ID: 28428062
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
